The Global Dermatology Lasers Industry is set to witness a transformative surge, projecting a steady compound annual growth rate (CAGR) of 7.0% between 2023 and 2033. According to the latest findings by Future Market Insights (FMI), the market is anticipated to ascend from its initial value of US$ 1,767.8 billion in 2023 to an impressive US$ 3,487.8 billion by 2033.
This comprehensive forecast underscores the robust momentum within the dermatology lasers industry, attributing the growth to technological advancements, rising aesthetic consciousness, and an expanding patient pool seeking advanced skincare solutions.
The Prevalence of Skin Problems is Increasing
Skin disorders and cosmetic issues are accurately targeted and treated with specialized lasers in laser dermatology. The availability of beauty and dermatological laser treatments, rising population spending power, the increased popularity of cosmetic surgery, and the presence of top dermatology laser machine providers are the important factors expected to shape the dermatology laser sector.
The high prevalence of skin cancer is anticipated to impact laser treatment adoption, resulting in increased dermatology laser sales. Furthermore, medical device research and development talents are becoming more prevalent as new healthcare technologies are implemented.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-12662
The growing elderly population and increasing healthcare infrastructure development expenditures in developing economies are two main factors bolstering the growth of the dermatological lasers market. The industry is experiencing tremendous growth as a result of increased demand in the beauty and personal care sectors, however, some factors are limiting its growth.
The high cost of laser treatment, skin discoloration in some situations, the danger of skin infection, and the heat released by the laser that might permanently damage the retina of the eye are factors affecting the market growth.
Hair removal and face rejuvenation are expected to remain the most popular dermatology laser application areas, owing to increased consumer spending on appearance maintenance.
Skin lasers are medical devices that use concentrated beams of light to treat a variety of skin conditions. These lasers are commonly used in dermatology practices and can be classified into several categories based on the wavelength of the light they emit.
Key Points from the Global Dermatology Lasers Industry:
- The market is expected to surpass US$ 3,487.8 billion by 2033.
- Important factors driving market expansion include increased incidences of skin disorders such as psoriasis and vitiligo around the world, which are expected to propel the worldwide market.
- The dermatology lasers market is expected to secure a CAGR of 7.0% during the forecast period 2023 to 2033.
- North America dominated the dermatology lasers market.
Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12662
Key Developments in the Global Dermatology Lasers Industry
- January 2020 – Nurnberg, Germany, announced the release of the groundbreaking applicator ClearSkin PRO. This product has twice the strength of previous remedies, resulting in skin that seems to be younger.
- July 2018 – Candela Corporation reported that its Vbeam Prima, an advanced 595 nm pulsed dye laser, had received FDA approval (PDL). This product includes a new 1,064 nm wavelength as well as other innovative features that can successfully treat a wide range of skin diseases.
- February 2021 – POETYK PSO-2, the second pivotal Phase III clinical trial investigating deucravacitinib, a new, selective tyrosine kinase 2 inhibitor for the treatment of patients with moderate to severe plaque psoriasis, was announced by Bristol Myers Squibb Company. POETYK PSO-2 compared deucravacitinib 6 mg once daily to placebo and met both co-primary objectives, with significantly more patients reaching Psoriasis Area and Severity Index (PASI 75).
- May 2020 – Dupixent (dupilumab) was approved by the United States Food and Drug Administration (FDA) for the treatment of moderate-to-severe atopic dermatitis.
- April 2020 – JUBLIA (efinaconazole) topical solution for the treatment of onychomycosis was approved by the United States Food and Drug Administration (FDA) for Bausch Health Companies Inc. and its dermatology business Ortho Dermatologics.
Get Ahead with Comprehensive Information – Purchase Now!
https://www.futuremarketinsights.com/checkout/12662
Key Companies Profiled in the Global Dermatology Lasers Industry:
- Cutera, Inc.
- Cynosure, Inc.
- Alma Laser
- En.
- Candela Medical
Global Dermatology Lasers Industry Key Segmentation
By Product:
- Solid-state Lasers
- Diode Lasers
- Nd:YAG Lasers
- Er:YAG Lasers
- Gas Lasers
- CO2 Lasers
- Excimers Lasers
- Pulsed Dye Lasers
By Technology:
- Ablative Lasers
- Non-ablative Lasers
By Application:
- Hair Removal
- Facial Rejuvenation
- Tattoo Removal
- Scar Treatment
- Skin Cancer
- Psoriasis
- Vitiligo
- Varicose Veins
- Actinic Keratosis
- Wound Treatment
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Dermatology & Cosmetic Clinics
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
